General Information
BounceWatch is an independent company data service, not affiliated with Roche. To contact Roche, visit sequencing.roche.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Roche compare?
A PDF of Roche and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Roche soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Roche on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Switzerland Market
Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.
Roche Africa and partners trained over 180 health workers and screened more than 23,000 women in its first phase.
The US FDA has approved Roche's product, Gazyva, as the first treatment for primary membranous nephropathy.
Roche's Global Medical Director for Neurosciences Ashton Harper discussed early Alzheimer’s diagnosis with Professor Catherine Loveday.
Roche ranked 6th in the 2026 Access to Medicine Index by the Access to Medicine Foundation.
Roche Diagnóstica implemented Ecuador's first automated post-analytical solution at Hospital de Especialidades Carlos Andrade Marín.
About Roche
No funding data available for Roche yet.
Latest News
View AllFAQ About Roche
Source: BounceWatch company record for Roche, https://bouncewatch.com/company/roche-sequencing-solutions, updated 17 November 2026. When citing, please name BounceWatch and link this page.